INTRODUCTION
Invasive infections caused by ubiquitous fungi of the genus Aspergillus are often encountered in immunocompromised patients with high degree of neutropenia. Pathogenic species of Aspergillus, particularly Aspergillus fumigatus, are the causative agents of a variety of pulmonary diseases in human including invasive aspergillosis, allergic bronchopulmonary aspergillosis and aspergilloma to mention a few (1) . Invasive aspergillosis is difficult to diagnose and successful treatment depends on the early detection of the fungus (2) . Current methods of diagnosis Author for correspondence Dr. P.Usha Sarma, at above address include direct microscopy, culture and immunodiagnosis. Microscopy is simple and rapid but not sensitive. Culture is sensitive and more specific but takes several days for diagnosis. Immunodiagnosis is not useful for the detection of invasive aspergillosis because of the immunosupressed state of patients (2) . Therefore, nucleic acid based identification of Aspergillus species is prudent in the detection of the desease. Polymerase chain reaction (PCR)) has replaced the conventional techniques for the rapid diagnosis of infectious agents in human diseases. DNA amplification methods enable genetic typing of the isolates. Random amplification of polymorphic DNA (RAPD) typing allows distinction between isolates of A.fumigatus (3).
The gene for major diagnostically relevant antigens/allergens has been cloned and sequenced from A.fumigatus of clinical origin (4) (5) (6) . Cloning and sequencing of the gene from A.fumigatus isolated from different clinical specimens showed identical amino acid sequence (4) (5) (6) . A 480 bp PCR product was detected in the sputa and bronchial aspirates of patients with aspergillosis diseases but not in the healthy controls. The method is rapid, dependable and was adopted to screen a large number of clinical samples using colorimetirc PCR.
MATERIALS AND METHODS
Isolation of A.fumigatus from clinical specimens : Sputa and bronchial aspirates from patients were obtained from the Department of Medical Mycology, Vallabhbhai Patel Chest Institute, Delhi and Rajan Babu Tuberculosis Hospital, Delhi. Fresh morning sputum samples and bronchial aspirates were collected aseptically. The thick, viscous sputum specimens were digested with 1% pancreatin in phosphate buffer pH-7.5 and subsequent incubation at 37~ for one and a half hour. Bronchial aspirates were centrifuged at 2000 rpm for 10 minutes and the supematent was discarded. Each specimen was divided into three parts, one part each for direct microscopy, culture and PCR. One part was subjected to direct microscopy to look for the presence of hyaline, septate hyphae characteristic of Aspergil/us species. 0.5 ml from each specimen was used for inoculation on dextrose agar with and without chloramphenicol (Emmons modification) and incubated at 25~ and 37~ one set each for 1-2 weeks. Seven control specimens, culture negative and seronegative to Afumigatus, from healthy individuals were also processed similarly for controis.
Isolation of DNA from A.fumigatus in the clinical samples : The remainder of the specimen was centrifuged at 3500xg for 20 min and the pellets were suspended in 0.2ml of 0.1 M phosphate buffer pH-6.8. (N/15 Sorenson's phosphate buffer). Chitinase (0.5U) was added to each tube and incubated for 1 h at 25~ Tubes were then heated three times in a microwave oven for 3 sec. cycles each (7) . Debris from the chitinase treated sputa and bronchial aspirate was pelleted by centrifugation at 12,000 x g for 10 min. The supernatant was siphoned off and the pellet containing fungal cells was emulsified by vigorous vortexing in 100 pl of chloroform. Distilled water (501JI) was added and emulsified with the chloroform phase. After centrifugation at 12,000 x g for 10 rain. the upper aqueous phase was collected. The samples containing the chromosomal DNA were stored at-20~ with chloroform, if not used immediately, and were recentrifuged prior to use.
Isolation of genomic DNA from Aspergillus species : A.fumigatus and A.flavus strains were grown in asparagine broth. Mycelia were harvested after three days, filtered and washed several times with sterile distilled water. Mycelial mat was made into a paste by grinding in a mortar under liquid nitrogen. Fungal cells were suspended in 0.1 M phosphate buffer, pH 6.8 (1 gm wet weight/mL), and treated with 0.5 U chitinase per mL of cell suspension of 1 h at 25~ Equal volume of lysis buffer (50mM Tris-CI, was added to the cell suspension and cells were treated in a microwave as described above. DNA was precipitated with ethanol after phenol: chloroform extraction as described (8) . Synthesis of PCR primers : Oligonucleotide pdmers for the 5' and 3' ends of the gene were designed based on the DNA sequence of the gene from A.fumigatus. (9) The oligonucleotides were synthesized on an Applied Biosystems Model 380B DNA synthesizer. Polymerase chain reaction : PCR mix was prepared in a clean dedicated area using all sterile pipet tips and microfuge tubes. Each PCR reaction mixture contained 10 pl of 10 x reaction buffer (100 mM Tris-CI, pH 8.3, 500 mM KCI), 10pl of 25mM MgCI 2, 10 pl of 10 x dNTP stock (2.0 mM each of dATP, dCTP, dGTP and 1.3 mM dTTP), 10 IJI of 0.07 mM digoxigenin-11-dUTP, 17 pl of 0.3 mM biotinylated -11-dUTP, and 3 pl of each primer (0.2 pM). Clinical DNA sample (25 pl) was added and the reaction volume was made upto 100 pl with water. Amplitaq DNA polymerase (0.5 pl-2.5U) was added, mixed, spun briefly, and overlaid with 100 pl of mineral oil. PCR was carried out in a Perkin Elmer Cetus, model No.4800, thermal cycler. The reaction conditions were; melting temperature at 92~ for 1 min, annealing temperature at 50~ for 1.5 min, and primer extension temperature at 72~ for 1 min for 30 cycles. Agarose gel electrophoresis : At the end of the reaction, 100 pl of chloroform was added, mixed and centrifuged briefly. Ten microliters of the PCR product in the upper aqueous layer was subjected to electrophoresis in a 1% agarose gel containing 0.5-1 IJg ethidium bromide per ml and visualized with UV light. Colorimetric detection of PCR product : Each well of microtitre plate was coated with100 IJI of streptavidin (10tJg/ml in 50 mM carbonate buffer, pH 9.6) for 1 h at 37~
Wells were rinsed twice in Tris buffered saline, pH 7.5 containing 0.5% (V/V) Tween-20 (TBS-T20). Ten microliters of PCR product was diluted to 100 IJI in TBS-T20 and added to each well. The plate was incubated for 30 min at 37~
The biotinylated PCR product was captured in the streptavidincoated microtitre well. The wells were rinsed twice with TBS-T20 and 100 IJI of antidigoxigenin alkaline phosphatase conjugate diluted to 1:5000 in TBS-T20 was added to each well. After 30 min of incubation at room temperature, wells were washed thoroughly with TBS-T20 to remove the unbound conjugate. One hundred microliters of paranitrophenylphosphate (PNPP) in 50 mM carbonate buffer, pH 9.6, containing 1 mM each of MgCI 2 and CaCI 2 was added to each well and the plate was incubated at room temperature for 30 min. The optical density of the reaction product was read at 405 rim. Immunodiffusion : Immunodiffusion was performed with the sera samples of all the patients using a well defined antigen fraction of A.fumigatus according to the method of Ouchterlony (10) as modified by Banerjee et al (11) . ELISA : Sera of patients were tested by IN-DIRECT ELISA for specific IgE and IgG antibodies to A.fumigatus antigen as described (12) . Materials : Pancreatin, chitinase, ethidium bromide, tween 20, tris (hydroxymethyl) aminomethane, sodium dodecylsulfate, mineral oil, Bio-11-UTP were purchased from Sigma Chemical Co, St.Louis, MO. PCR kit containing Taq polymerase, dNTPs and buffer was purchased from Perkin Elmer Cetus, Foster City, CA. Streptavidin, dig-11-dUTP, antidigoxigenin, alkaline phosphatase were obtained from Boehringer Mannheim, Specific oligonucleotide primers were synthesized based on the nucleotide sequence of the gene for the 16.9 kDa virulence factor/antigen of Afumigatus. All other chemicals used in this study were Excelar/GR grade.
RESULTS

Culture and Microscopy of Clinical Samples :
Out of nineteen clinical samples tested by microscopy and culture, eleven were found to be positive. The other four samples were found to be culture and microscopy negative ( Table 1) . Sera of the same patients were tested by both immunodiffusion and ELISA. Consistent with culture and microscopy, identification of Aspergillus species by immunodiffusion and ELISA techniques were positive for culture positive specimens and negative for culture negative specimens. Detection of A.fumigatus by PCR. : Polymerase chain reaction of A.fumigatus genomic DNA (9). It is worthwhile noting that a similar amplification using A.f7avus genomic DNA did not produce any PCR product., This observation formed the basis for PCR based rapid diagnosis of a variety of diseases caused by A.fumigatus.
Detection of A.fumigatus in clinical samples
by PCR 9 Fifteen clinical samples, out of the nineteen tested, that were positive by culture and microscopy also tested positive by PCR (9) . Amplification of one of the negative specimens by culture and microscopy failed to yield the 480 bp product (9) . Colorimetric immuno-PCR : Analysis and handling of a large number of PCR products by agarose gel electrophoresis is laborious. We have instead chosen to analyze a large number of PCR products by immuno-screening in a microtitre plate. In the amplification protocol, biotinylated and digoxigenin labeled dUTP was included along with dNTPs to obtain biotinylated and digoxigenin labeled DNA fragment. The labeled DNA fragment was bound to streptavidin coated wells and coupled to the antidigoxigenin alkaline phosphatase conjugate and the PCR product was quantitated by reaction with paranitrophenylphosphate and the absorbance was measured at 405nm. The absorbance for PCR positive clinical samples from patients with asperigillus infection was in the range of 0.9 to 1.5 whereas the absorbance for PCR negative clinical samples from normal control humans was about 0.2
DISCUSSION
Polymerase chain reaction has been proven to be an invaluable tool for the diagnosis of infectious diseases in the field of clinical micro- The protocol for clinical sample preparation offers significant advantage over the current procedures of sample treatment. The DNA extraction procedure described here is simple and efficient. It is performed in a short period, avoids mechanical disruption of cells and the use of phenol extraction. Apart from the microwave oven no special equipment is needed. This protocol may be adopted for organisms other than Aspergillus species.
The sensitivity and specificity of PCR methods are reported to be far greater than those of the culture method for detection of tuberculosis (21) (12) in a microtitre plate would be more convenient and effecient to perform. In this study we developed a colorimetric PCR assay for the detection A.fumigatus. The method is based on labeling the PCR product with biotin and digoxigenin and binding the PCR productto streptavidin coated microtitre wells. The bound digoxigenin labeled DNA was coupled to antigoxigenin alkaline phosphatase and the color was developed with paranitrophenyt phosphate. The colorimetric detection of PCR products was found to be at least as sensitive and specific as agarose gel electrophoresis and is useful for analysing a large number of samples. Since the samples are analyzed in a microtitre plate, 96 samples can be analyzed at a time. Color intensity can be measured with the help of ELISA reader and the quantitation of DNA may be possible. Positive samples can also be identified by the presence of color in the wells against control. This test may be used for screening large number of samples.
